Sage Journals: Discover world-class research

Abstract

Purpose

To present a case series of percutaneous sclerotherapy of para-orbital and orbital venous malformations.

Method

Seven patients with venous malformations in the orbital and para-orbital region were reviewed. Puncture venogram was performed on all patients and image guided bleomycin injections using biplane digital subtraction in angiography suite.

Results

Average age of patients at the time of the procedure was 22 years old with the youngest being five years of age and the oldest being 50 years. Follow-ups ranged from 3 months to 18 months and the average follow-up duration was 13 months. The patients had no intraprocedural complications and reported symptomatic relief of pain as per the last follow-up. Patients have shown no symptoms or signs of recurrence of lesions with uneventful recovery so far.

Conclusions

Percutaneous sclerotherapy of orbital Venous Malformations with bleomycin is a safe and well-controlled procedure done in real time; it has no major systemic adverse side effects and higher efficacy than other sclerosing agents.

Keywords

Sclerotherapy venography venous disease

Get full access to this article

View all access options for this article.

References

Vadlamudi, V, et al. Transvenous sclerotherapy of a large symptomatic orbital venous varix using a microcatheter balloon and bleomycin. Journal of Neurointerventional Surgery 2016; 8(8): e30–e30.

Chen

Zhu

et al . Fluoroscopic intralesional injection with pingyangmycin lipiodol emulsion for the treatment of orbital venous malformations. Am J Roentgenol 2008; 190: 966–971.

Bajpai

Comparative analysis of intralesional sclerotherapy with sodium tetradecyl sulfate versus bleomycin in the management of low flow craniofacial soft tissue vascular lesions.

J Maxillofac Oral Surg 2012; 11: 13–20.

Pimpalwar

Vascular malformations: approach by an interventional radiologist. Semin Plast Surg 2014; 28: 91.

Bhatnagar

Upadhyaya

Kumar

et al . Aqueous intralesional bleomycin sclerotherapy in lymphatic malformation: our experience with children and adult. Natl J Maxillofac Surg 2017; 8: 130.

Dabus G and Benenati JF. Interventional treatment options for vascular malformations. Endovascular Today, April 2013, evtoday.com/2013/04/interventional-treatment-options-for-vascular-malformations/ (accessed 10 September 2018).

Benoiton

Chan

Steiner

et al . Management of orbital and periorbital venous malformation. Front Surg 2017; 4: 27.

Sio

Lee

Liang

IC.

Orbital infarction syndrome after multiple percutaneous sclerotherapy sessions for facial low-flow vascular malformation: a case report and literature review.

Indian J Ophthalmol 2016; 64: 595.

Raichura, Nirav D., et al. A prospective study of the role of intralesional bleomycin in orbital lymphangioma. Journal of American Association for Pediatric Ophthalmology and Strabismus 2017; 21(2): 146–151.